1 / 11

AUGMENTATION DE L’INCIDENCE DE LA COQUELUCHE DANS LE MONDE ?

AUGMENTATION DE L’INCIDENCE DE LA COQUELUCHE DANS LE MONDE ?. Diagnostic biologique plus performant Couverture vaccinale insuffisante Adoption des acellulaires dans de nombreux pays Moins efficace ? Durée de protection moins longue ? Modification des souches…vaccins moins efficaces.

daryl
Download Presentation

AUGMENTATION DE L’INCIDENCE DE LA COQUELUCHE DANS LE MONDE ?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. AUGMENTATION DE L’INCIDENCE DE LA COQUELUCHE DANS LE MONDE ? • Diagnostic biologique plus performant • Couverture vaccinale insuffisante • Adoption des acellulaires dans de nombreux pays • Moins efficace ? • Durée de protection moins longue ? • Modification des souches…vaccins moins efficaces

  2. Pourquoi vacciner contre la coqueluche ? • Eradiquer la maladie : Non • Protéger d’une maladie grave chez le petit nourrisson +++ • Protéger d’une maladie gênante chez le grand enfant et l’adulte + • Assurer une immunité de groupe protégeant contre les grandes épidémies +

  3. Pourquoi vacciner les adultes contre la coqueluche ? • Eradiquer la maladie • Les protéger d’une maladie gênante, exceptionnellement grave • Les empêcher de contaminer les petits enfants • Assurer une immunité de groupe protégeant contre les grandes épidémies

  4. Review of Randomized Trials • Conclusions • aP vaccines effective in preventing confirmed pertussis • Marginally less effective than the best wP vaccines • 1,2,3, and 5 component vaccines all effective • Notably, no resurgence in Denmark despite monocomoponent vaccine • No simple relationship between immunogenicity and efficacy

  5. Baboon Study Animal Model Attribution: Tod J. Merkel et al Laboratory of Respiratory and Special Pathogens CBER/FDA

  6. wP and aP both protective against disease Animal Model (Baboon Study) Attribution: Tod J. Merkel et al Laboratory of Respiratory and Special Pathogens CBER/FDA

  7. aP did not prevent infection Animal Model (Baboon Study) Attribution: Tod J. Merkel et al Laboratory of Respiratory and Special Pathogens CBER/FDA

  8. Animal Model (Baboon Study) • aP did not prevent transmission Attribution: Tod J. Merkel et al Laboratory of Respiratory and Special Pathogens CBER/FDA

  9. Animal Model (Baboon Study) • Conclusions • Infection, wP, aP all protected against symptomatic disease • wP provided some sterilizing immunity • Less than natural infection • Induces Th1 and Th17 memory • aP did not prevent infection and transmission • Higher Th2 but lower Th1 and Th17 responses • Lack of mucosal immunity induction likely has role in pertussis resurgence References Warfel JM, Beren J, Kelly VK, Lee G, Merkel TJ. Nonhuman primate model of pertussis. Infect Immun 2012;80(4):1530-1536. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci 2014;111(2):787-792. Warfel JM, Papin JF, Wolf RF, Zimmerman LI, Merkel TJ. Maternal and neonatal vaccination protects newborn baboons from pertussis infection. J Infect Dis 2014.

  10. Summary • Pertussis vaccination very effective in reducing disease • wP and aP both effective in reducing infant mortality • No evidence of broad resurgence at global level • Cyclic recurrent patterns of pertussis still observed • aP disease prevention • Lower initial efficacy and faster waning of immunity • Reduced impact on infection and transmission • Modelling and baboon data support hypothesis that wP to aP transition is associated with localized disease resurgence

  11. Si on veut protéger les petits enfants • Vaccination précoce +++ 6 semaines (moins) • Vaccination des femmes enceintes +++ • Cocooning +

More Related